These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8550206)

  • 21. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of dose-response relationships in BALB/c mice, using Brucella cell surface protein and lipopolysaccharide.
    Pugh GW; Tabatabai LB; Phillips M; McDonald TJ
    Am J Vet Res; 1991 Feb; 52(2):261-8. PubMed ID: 1901465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of DNA vaccine encoding BCSP
    Imtiaz W; Khan A; Gul ST; Saqib M; Saleemi MK; Shahzad A; Dong J; Hussain R; Shen M; Du X
    Microb Pathog; 2018 Dec; 125():514-520. PubMed ID: 30321591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
    Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
    Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.
    Jiménez de Bagüés MP; Elzer PH; Jones SM; Blasco JM; Enright FM; Schurig GG; Winter AJ
    Infect Immun; 1994 Nov; 62(11):4990-6. PubMed ID: 7927779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51.
    Stevens MG; Olsen SC
    Infect Immun; 1996 Mar; 64(3):1030-4. PubMed ID: 8641754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a virulence factor for Brucella abortus infection in BALB/c mice.
    Pugh GW; Tabatabai LB; Bricker BJ; Mayfield JE; Phillips M; McDonald TJ; Zehr ES
    Am J Vet Res; 1989 Jun; 50(6):887-92. PubMed ID: 2504086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation by western blotting of immune responses of cattle vaccinated with Brucella abortus strain 19 or infected experimentally or naturally with virulent Brucella abortus.
    Belzer CA; Tabatabai LB; Deyoe BL
    Vet Microbiol; 1991 Mar; 27(1):79-90. PubMed ID: 1904667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
    Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
    Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB/c mice.
    Lin GZ; Yang JT; Wei SC; Chen SE; Huo SD; Ma ZR
    Trop Anim Health Prod; 2018 Jun; 50(5):957-963. PubMed ID: 29492808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.
    Willett JW; Herrou J; Czyz DM; Cheng JX; Crosson S
    Vaccine; 2016 Sep; 34(42):5073-5081. PubMed ID: 27591954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice.
    Rosinha GM; Freitas DA; Miyoshi A; Azevedo V; Campos E; Cravero SL; Rossetti O; Splitter G; Oliveira SC
    Infect Immun; 2002 Sep; 70(9):5036-44. PubMed ID: 12183550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of immune responses to a GroEL heat shock protein in preventing brucellosis in mice vaccinated with Brucella abortus strain RB51.
    Stevens MG; Olsen SC; Pugh GW; Mayfield JE
    Comp Immunol Microbiol Infect Dis; 1997 Feb; 20(2):147-53. PubMed ID: 9208200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.
    Kaushik P; Singh DK; Kumar SV; Tiwari AK; Shukla G; Dayal S; Chaudhuri P
    Vet Res Commun; 2010 Feb; 34(2):119-32. PubMed ID: 20013309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.
    Stevens MG; Olsen SC; Pugh GW
    Infect Immun; 1995 Aug; 63(8):3199-205. PubMed ID: 7622248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.